Genor Biopharma Holdings Limited

HKEX:6998.HK

1.65 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 1,026.5671,026.5671,165.4811,165.4811,361.9711,361.9711,588.7051,588.7051,858.1811,858.1812,200.6412,200.6412,579.1492,579.1492,929.7432,929.743-196.836196.836-125.158
Short Term Investments 0000000000000000393.6720250.316
Cash and Short Term Investments 1,026.5671,026.5671,165.4811,165.4811,361.9711,361.9711,588.7051,588.7051,858.1811,858.1812,200.6412,200.6412,579.1492,579.1492,929.7432,929.743196.836196.836125.158
Net Receivables 0000000000000000000
Inventory 5.5015.5015.6675.66733.64433.64447.40447.40446.49646.49649.65349.65343.67943.67931.46531.465023.0550
Other Current Assets 60.13360.13369.97569.97569.64869.64884.04484.04492.3292.32136.284136.284116.654116.654140.199140.199076.8230
Total Current Assets 1,092.2011,092.2011,241.1231,241.1231,465.2631,465.2631,720.1531,720.1531,996.9971,996.9972,386.5782,386.5782,739.4822,739.4823,101.4073,101.407196.836296.714125.158
Non-Current Assets:
Property, Plant & Equipment, Net 41.89641.89660.13760.137193.954193.954205.217205.217243.77243.77223.367223.367217.677217.677229.163229.1630220.1950
Goodwill 0017.81917.81917.81917.81921.75321.7530021.75321.75321.75321.75321.75321.753021.7530
Intangible Assets 104.458104.45892.2892.28127.206127.206141.455141.455166.486166.486149.29149.29149.586149.586135.183135.183074.0640
Goodwill and Intangible Assets 104.458104.458110.099110.099145.025145.025163.208163.208166.486166.486171.043171.043171.339171.339156.936156.936095.8170
Long Term Investments 00-8.350000000000000000
Tax Assets 008.3507.60806.91307.94405.73209.17100001.5090
Other Non-Current Assets 35.76635.76635.51835.51822.64930.25719.626.51312.53920.48376.12181.853136.443145.61485.94385.943-196.83664.948-125.158
Total Non-Current Assets 182.12182.12205.754205.754369.236369.236394.938394.938430.739430.739476.263476.263534.63534.63472.042472.042-196.836382.469-125.158
Total Assets 1,274.3211,274.3211,446.8771,446.8771,834.4991,834.4992,115.0912,115.0912,427.7362,427.7362,862.8412,862.8413,274.1123,274.1123,573.4493,573.4490679.1830
Liabilities & Equity:
Current Liabilities:
Account Payables 129.939129.939141.661152.214116.648127.887132.158156.76592.71495.1129.666153.47792.208104.537108.754108.7540112.790
Short Term Debt 1.1131.1133.2313.2319.8719.8716.7636.76314.77814.77837.30137.30114.86414.86415.04515.045013.4510
Tax Payables 001.84402.27102.23702.7803.50501.53600000.5640
Deferred Revenue 00-3.0660000000000000000
Other Current Liabilities 58.58658.58682.78974.0891.00482.036119.23796.867123.862124.256142.716122.41154.048143.255124.931124.9310263.3550
Total Current Liabilities 189.638189.638229.525229.525219.794219.794260.395260.395234.134234.134313.188313.188262.656262.656248.73248.730390.160
Non-Current Liabilities:
Long Term Debt 2.0352.0353.9243.92423.69123.69121.82321.82340.02840.02820.10720.10717.37817.37816.01416.014026.7810
Deferred Revenue Non-Current 0010.574012.137013.984015.83018.149020.944000022.8710
Deferred Tax Liabilities Non-Current 0011.595012.017012.439012.86013.282013.703000014.7570
Other Non-Current Liabilities 19.30619.30622.72822.72825.06225.0621.23227.65532.04732.04736.43536.43567.34667.34671.5871.580116.4610
Total Non-Current Liabilities 21.34121.34126.65226.65248.75348.75349.47849.47872.07572.07556.54256.54284.72484.72487.59487.5940143.2420
Total Liabilities 210.979210.979256.177256.177268.547268.547309.873309.873306.209306.209369.73369.73347.38347.38336.324336.3240533.4020
Equity:
Preferred Stock 00001,430.16101,452.20401,450.43401,409.82401,375.1060000181.3710
Common Stock 0.070.070.0690.0690.0690.0690.0690.0690.0690.0690.0680.0680.0670.0670.0670.06700.0390
Retained Earnings -6,916.031-6,916.031-6,790.336-6,790.336-6,390.526-6,390.526-6,115.974-6,115.974-5,791.391-5,791.391-5,385.76-5,385.76-4,921.429-4,921.429-4,520.536-4,520.5360-1,635.3990
Accumulated Other Comprehensive Income/Loss -1,493.499-1,493.499-1,413.572-1,413.572-1,430.161-1,430.161-1,452.204-1,452.204-1,450.434-1,450.434-1,409.824-1,409.824-1,375.106-1,375.106-1,426.445-1,426.445139.859-181.371823.604
Other Total Stockholders Equity 9,471.5069,471.5069,392.6539,392.6539,384.3219,384.3219,370.5879,370.5879,361.3489,361.3489,285.7059,285.7059,221.7799,221.7799,180.9679,180.9675.9221,956.590
Total Shareholders Equity 1,062.0461,062.0461,188.8141,188.8141,563.7031,563.7031,802.4781,802.4782,119.5922,119.5922,490.1892,490.1892,925.3112,925.3113,234.0533,234.053145.781139.859823.604
Total Equity 1,063.3421,063.3421,190.71,190.71,565.9521,565.9521,805.2181,805.2182,121.5272,121.5272,493.1112,493.1112,926.7322,926.7323,237.1253,237.125145.781145.781823.604
Total Liabilities & Shareholders Equity 1,274.3211,274.3211,446.8771,446.8771,834.4991,834.4992,115.0912,115.0912,427.7362,427.7362,862.8412,862.8413,274.1123,274.1123,573.4493,573.449145.781679.183823.604